PubRank

Motohiro Matoba

Author PubWeight™ 15.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations. Jpn J Clin Oncol 2013 0.90
2 Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain 2011 0.88
3 A region-based palliative care intervention trial using the mixed-method approach: Japan OPTIM study. BMC Palliat Care 2012 0.84
4 Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis. Synapse 2011 0.83
5 Population pharmacokinetics of transdermal fentanyl in patients with cancer-related pain. J Pain Palliat Care Pharmacother 2012 0.83
6 Usefulness of olanzapine as an adjunct to opioid treatment and for the treatment of neuropathic pain. Anesthesiology 2012 0.83
7 Public awareness, knowledge of availability, and readiness for cancer palliative care services: a population-based survey across four regions in Japan. J Palliat Med 2011 0.82
8 Sensation of abdominal pain induced by peritoneal carcinomatosis is accompanied by changes in the expression of substance P and μ-opioid receptors in the spinal cord of mice. Anesthesiology 2012 0.82
9 Pharmacokinetics of oxycodone after intravenous and subcutaneous administration in Japanese patients with cancer pain. J Pain Palliat Care Pharmacother 2014 0.81
10 [A phase II clinical study of once-a-day fentanyl citrate patch in patients with cancer pain--switching from once-every-three-days fentanyl patch to once-a-day fentanyl citrate patch]. Gan To Kagaku Ryoho 2010 0.79
11 [Efficacy and safety of continuous subcutaneous injection of the compound oxycodone in cancer pain management: the first 4-year audit]. Gan To Kagaku Ryoho 2009 0.77
12 Prevalence of analgesic prescriptions among patients with cancer in Japan: an analysis of health insurance claims data. Glob J Health Sci 2012 0.77
13 Survey on recognition of post-mastectomy pain syndrome by breast specialist physician and present status of treatment in Japan. Breast Cancer 2012 0.77
14 Distinct TRPV1- and TRPA1-based mechanisms underlying enhancement of oral ulcerative mucositis-induced pain by 5-fluorouracil. Pain 2016 0.77
15 Population pharmacokinetics of oxycodone in patients with cancer-related pain. J Pain Palliat Care Pharmacother 2012 0.76
16 Baclofen as an adjuvant analgesic for cancer pain. Am J Hosp Palliat Care 2008 0.76
17 Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain. Biol Pharm Bull 2007 0.76
18 Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia. Synapse 2012 0.76
19 Determination of oxycodone and hydrocotarnine in cancer patient serum by high-performance liquid chromatography with electrochemical detection. Anal Sci 2005 0.76
20 Knowledge, beliefs, and concerns about opioids, palliative care, and homecare of advanced cancer patients: a nationwide survey in Japan. Support Care Cancer 2011 0.76
21 Mandatory palliative care education for surgical residents: initial focus on teaching pain management. Jpn J Clin Oncol 2012 0.75
22 [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan]. Gan To Kagaku Ryoho 2007 0.75
23 [Pharmacokinetics of controlled-release oxycodone in patients with cancer pain]. Gan To Kagaku Ryoho 2007 0.75
24 Analysis of factors related to the use of opioid analgesics in regional cancer centers in Japan. J Palliat Med 2010 0.75
25 [Retrospective study on intravenous compound injection of cancer pain patients with oxycodone and hydrocotarnine preparation in comparison with subcutaneous administration]. Gan To Kagaku Ryoho 2012 0.75
26 [Evaluation of the 2.5 mg fentanyl patch, applied using the half-side application procedure in patients with cancer pain]. Yakugaku Zasshi 2008 0.75
27 Novel method of determination of D9-tetrahydrocannabinol(THC) in human serum by high-performance liquid chromatography with electrochemical detection. Gan To Kagaku Ryoho 2014 0.75
28 [Solutions for the clinical problems of analgesics for cancer pain treatment in Japan]. Yakugaku Zasshi 2011 0.75
29 Recent developments in the management of cancer pain in Japan: education, clinical guidelines and basic research. Jpn J Clin Oncol 2012 0.75
30 Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity. Anesth Analg 2015 0.75
31 [Efficacy and safety of compound oxycodone injection for cancer pain relief-a multicenter survey of prescriptions]. Gan To Kagaku Ryoho 2010 0.75
32 [Conversion ratio between intravenous oxycodone/hydrocotarnine and sustained-release oral oxycodone in patients with cancer pain]. Gan To Kagaku Ryoho 2007 0.75